**High population immunity from prior infections and vaccination, combined with ongoing but low-level SARS-CoV-2 circulation, underpins the 95.5% market-implied odds against a new coronavirus pandemic emerging in 2026.** As of late 2026, WHO maintains a moderate global risk assessment, with hospitalizations and deaths far below earlier peaks and no variants under monitoring (such as XFG or BA.3.2 sublineages) demonstrating increased severity or pandemic potential. CDC respiratory surveillance shows declining or stable national activity, low wastewater signals in many areas, and continued evolution within Omicron-descended lineages that primarily confer immune escape rather than heightened virulence. Genomic monitoring through agencies like CDC and WHO indicates sustained but manageable transmission, consistent with an endemic respiratory virus pattern. Realistic shifts could arise from a novel spillover event or a variant acquiring both substantial immune escape and enhanced pathogenicity, though current data and model consensus make rapid escalation unlikely before year-end. Ongoing sentinel and wastewater surveillance updates will provide the next key signals.